SNUBH Urology

Medicine and Dentistry

1. Patient 100%
2. Prostate Cancer 62%
3. Prostatectomy 36%
4. Inpatient 32%
5. Clear Cell Renal Cell Carcinoma 31%
6. Man 28%
7. Prostate Specific Antigen 23%
8. Analysis 22%
9. Biopsy 20%
10. Neoplasm 19%
11. Gleason Score 17%
12. Surgery 15%
13. Age 14%
14. Partial Nephrectomy 13%
15. Association 11%
16. Prostate Biopsy 11%
17. Survival 11%
18. Biochemical Recurrence 11%
19. Malignant Neoplasm 11%
20. Serum 10%
21. Disease 10%
22. Lower Urinary Tract Symptom 9%
23. Robot-Assisted Prostatectomy 9%
24. Follow up 9%
25. Radical Nephrectomy 9%
26. Prostate 8%
27. Magnetic Resonance Imaging 8%
28. Cancer Specific Survival 8%
29. Overall Survival 8%
30. Transrectal Ultrasonography 7%
31. Recurrent Disease 7%
32. Diagnosis 7%
33. Surgical Margin 7%
34. Body Mass Index 7%
35. Symptom 7%
36. Transitional Cell Carcinoma 6%
37. Prognostic Factor 6%
38. Surveillance 6%
39. Continence 6%
40. Development 6%
41. Radical Retropubic Prostatectomy 6%
42. Prostate Hypertrophy 6%
43. Bladder 6%
44. Lesion 6%
45. Prognosis 6%
46. Evaluation Study 6%
47. Kidney Metastasis 5%
48. Hazard Ratio 5%
49. Kidney Tumour 5%
50. Accuracy 5%
51. Cancer Diagnosis 5%
52. Multivariate Analysis 5%
53. Biochemical Recurrence Free Survival 5%
54. Odds Ratio 5%
55. Survival Rate 5%
56. Specimen 5%
57. Combination Therapy 5%